Stella Pharmaceuticals Private Limited
About Stella Pharmaceuticals Private Limited
Data last updated:
Stella Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2010PTC204482. Its GSTIN is 27AAOCS4265Q1ZE (Maharashtra).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹16.5 Lakh. It is led by directors including Murlidhar Radhakisan Kewalramani and Amir Asghar Ali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ho No. 12/G Opposite Daga Hospital Gandhibagh Dwarka Sadan, Nagpur, Maharashtra, India – 440002.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.56 Lakh, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹3.67 Lakh (net margin 5.4%) and EBITDA of ₹4.48 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 209% over three years and 2% over five years.
The company is associated with 1 brand: Stella Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHo No. 12/G Opposite Daga Hospital Gandhibagh Dwarka Sadan, Nagpur, Maharashtra, India – 440002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals operates one associated brand: Stella Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wholesale trader and exporter of pharmaceutical medicines and injections. | stellapharmaceuticals.com |
Business Activity of Stella Pharmaceuticals Private Limited
The main business activity of Stella Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stella Pharmaceuticals Private Limited FY 2025 filings available
Stella Pharmaceuticals Private Limited reported revenue of ₹68.56 Lakh (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Stella Pharmaceuticals Private Limited
Revenue rose 131% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stella Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.48 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.67 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stella Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stella Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murlidhar Radhakisan Kewalramani | Director | 19 Jun 2010 | 16 Years 4 Months | Current |
| Amir Asghar Ali | Director | 19 Jun 2010 | 16 Years 4 Months | Current |
| Sushil Murildhar Kewalramani | Director | 05 Feb 2024 | 2 Years 8 Months | Current |
Peer Comparison of Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alchemist Hospitals (Gurgaon) Private Limited | ₹68.7 Lakh (FY 2018) | •••• | •••• | -53.0% | •••• | Panchkula, Haryana, India |
| Amnour Pharmaceuticals Private Limited | ₹68.69 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Pune, Maharashtra, India |
| Atreya Resorts for Traditional Healing Private Limited | ₹68.68 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | Bangalore, Karnataka, India |
| Avanza Life Sciences Private Limited | ₹68.64 Lakh (FY 2023) | •••• | •••• | -51.0% | •••• | Kalamassery, Kerala, India |
| Abhigyaan Labs Private Limited | ₹68.6 Lakh (FY 2024) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| Stella Pharmaceuticals Private Limited this company | ₹68.56 Lakh (FY 2025) | •••• | •••• | 131.0% | •••• | Nagpur, Maharashtra, India |
| Elara Pharmaceuticals Private Limited | ₹68.52 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Pune, Maharashtra, India |
| Daruvala Bros. Private Limited | ₹68.5 Lakh (FY 2025) | •••• | •••• | 54.0% | •••• | Mumbai, Maharashtra, India |
| Agron Pharma Private Limited | ₹68.41 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Agresco Pharma Private Limited | ₹68.35 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Mumbai, Maharashtra, India |
| Scinva Chemicals and Pharmaceuticals Private Limited | ₹68.23 Lakh (FY 2025) | •••• | •••• | 1569.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Stella Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Stella Pharmaceuticals Private Limited
Auditor information for Stella Pharmaceuticals Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Ownership and Shareholding of Stella Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Stella Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Stella Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Sushil Murildhar Kewalramani was appointed as Director on 05 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Stella Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stella Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stella Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCS4265Q1ZE | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stella Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stella Pharmaceuticals Private Limited
Stella Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 June 2010 (16+ years old) and is registered under CIN U51909MH2010PTC204482.
Stella Pharmaceuticals reported revenue of ₹68.56 Lakh for FY 2025 (up 131% YoY).
Stella Pharmaceuticals has 3 current directors:
- Murlidhar Radhakisan Kewalramani - Director
- Amir Asghar Ali - Director
- Sushil Murildhar Kewalramani - Director
Stella Pharmaceuticals reported a net profit of ₹3.67 Lakh (net margin 5.4%) and EBITDA of ₹4.48 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stella Pharmaceuticals is 209% over three years and -2% over five years. In the latest year (FY 2025) revenue rose 131%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stella Pharmaceuticals is 27AAOCS4265Q1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Stella Pharmaceuticals is U51909MH2010PTC204482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stella Pharmaceuticals was incorporated on 19 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Stella Pharmaceuticals by revenue are Alchemist Hospitals (Gurgaon) Private Limited, Amnour Pharmaceuticals Private Limited, Atreya Resorts for Traditional Healing Private Limited, Avanza Life Sciences Private Limited, Abhigyaan Labs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Sushil Murildhar Kewalramani was appointed as Director on 05 Feb 2024. Suhail Ishaque Naqvi ceased to be Director on 02 Aug 2021. Amir Asghar Ali was appointed as Director on 19 Jun 2010. Stella Pharmaceuticals has 4 board changes on record in total.
The registered office of Stella Pharmaceuticals is at Ho No. 12G Opposite Daga Hospital Gandhibagh Dwarka Sadan, Nagpur, Maharashtra, India – 440002.